Edition:
United Kingdom

Insider Trading: ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

20.17USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$20.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
868,330
52-wk High
$41.20
52-wk Low
$12.80

All Insider Trades
Trading Date Name Title Type Shares Traded Price
2 Mar 2018

Soland (Daniel B)

Director Buy 3,000 $22.52
1 Mar 2018

Soland (Daniel B)

Director Buy 2,000 $24.52
1 Mar 2018

Soland (Daniel B)

Director Buy 2,000 $23.02
1 Mar 2018

Soland (Daniel B)

Director Buy 3,000 $24.09
29 Jan 2018

Baity (Glenn F)

General Counsel Sell 36,558 $32.39
10 Jan 2018

Baity (Glenn F)

General Counsel Buy 50,179 $2.18
2 Jan 2018

Baity (Glenn F)

General Counsel Buy 74,321 $2.18
2 Jan 2018

Brege (Laura A)

Director Sell 25,000 $30.06
2 Jan 2018

Brege (Laura A)

Director Buy 15,000 $8.06
2 Jan 2018

Baity (Glenn F)

General Counsel Sell 74,321 $30.14
2 Jan 2018

Brege (Laura A)

Director Buy 10,000 $8.49
27 Nov 2017

BAKER BROS ADVISORS L P

Beneficial Owner of More than 10% Class Buy 39,378 $1.38
27 Nov 2017

BAKER BROS ADVISORS L P

Beneficial Owner of More than 10% Class Sell 1,941 $28.00
13 Oct 2017

BAKER BROS ADVISORS L P

Beneficial Owner of More than 10% Class Sell 55,457 $35.40
13 Oct 2017

BAKER BROS ADVISORS L P

Beneficial Owner of More than 10% Class Buy 1,426,590 $1.38
5 Oct 2017

Baity (Glenn F)

General Counsel Buy 20,000 $2.00
5 Oct 2017

Baity (Glenn F)

General Counsel Buy 1,000 $2.18
5 Oct 2017

Baity (Glenn F)

General Counsel Sell 37,500 $40.91
5 Oct 2017

Baity (Glenn F)

General Counsel Buy 7,500 $1.62
4 Oct 2017

Baity (Glenn F)

General Counsel Buy 4,500 $2.18
4 Oct 2017

Baity (Glenn F)

General Counsel Buy 6,500 $1.62
30 Aug 2017

Baity (Glenn F)

General Counsel Sell 26,507 $34.87
30 Aug 2017

Baity (Glenn F)

General Counsel Buy 16,507 $1.62
9 Aug 2017

Baity (Glenn F)

General Counsel Buy 922 $1.55
9 Aug 2017

Baity (Glenn F)

General Counsel Buy 13,400 $1.62

Institutional Holders

% Shares Owned: 96.42%
# of Holders: 283
Total Shares Held: 120,532,210
3 Mo. Net Change: -6,109,354
# New Positions: 44
# Closed Positions: 62
# Increased Positions: 140
# Reduced Positions: 132
# Net Buyers: 8

Officers & Directors

Name Age Since Current Position

Stephen Biggar

47 2016 Independent Chairman of the Board

Stephen Davis

57 2016 President, Chief Executive Officer, Director

Todd Young

46 2016 Executive Vice President, Chief Financial Officer

Austin Kim

52 2018 Executive Vice President, General Counsel, Secretary

Srdjan Stankovic

61 2015 Executive Vice President, Head - Research and Development

Michael Yang

56 2017 Executive Vice President, Chief Commercial Officer

Edmund Harrigan

65 2015 Director

Julian Baker

51 2016 Independent Director

Laura Brege

60 2008 Independent Director

James Daly

56 2016 Independent Director

Daniel Soland

60 2015 Independent Director

Lisa Barthelemy

2015 Senior Director, Investor Relations